Literature DB >> 24926031

Bioethical challenges with HIV treatment as prevention.

Jeremy Sugarman1.   

Abstract

To best realize the opportunities afforded by treatment as prevention, important ethical challenges must be addressed, including those related to acceptability, safety, and effectiveness, as well as alternatives. Absent universal access to quality antiretroviral treatment, safety, fairness, and allocation must also be considered.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV prevention; HIV treatment; ethics; policy

Mesh：

Substances：

Year:  2014        PMID： 24926031      PMCID： PMC4141494          DOI： 10.1093/cid/ciu246

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Treatment-as-prevention needs to be considered in the just allocation of HIV drugs.

Authors:  Bridget Haire
Journal:  Am J Bioeth       Date:  2011-12       Impact factor: 11.229

2.  Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

Authors:  Ingrid T Katz; Thandekile Essien; Edmore T Marinda; Glenda E Gray; David R Bangsberg; Neil A Martinson; Guy De Bruyn
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

3.  The world must build on three decades of scientific advances to enable a new generation to live free of HIV/AIDS.

Authors:  Anthony S Fauci; Gregory K Folkers
Journal:  Health Aff (Millwood)       Date:  2012-07       Impact factor: 6.301

4.  Given financial constraints, it would be unethical to divert antiretroviral drugs from treatment to prevention.

Authors:  Ruth Macklin; Ethan Cowan
Journal:  Health Aff (Millwood)       Date:  2012-07       Impact factor: 6.301

5.  Preventive misconception: its nature, presence, and ethical implications for research.

Authors:  Alan E Simon; Albert W Wu; Philip W Lavori; Jeremy Sugarman
Journal:  Am J Prev Med       Date:  2007-05       Impact factor: 5.043

6.  Antiretroviral resource allocation for HIV prevention.

Authors:  Jerome Amir Singh
Journal:  AIDS       Date:  2013-03-27       Impact factor: 4.177

7.  Ethical challenges in long-term funding for HIV/AIDS.

Authors:  Dan W Brock; Daniel Wikler
Journal:  Health Aff (Millwood)       Date:  2009 Nov-Dec       Impact factor: 6.301

8.  Ethics of ARV based prevention: treatment-as-prevention and PrEP.

Authors:  Bridget Haire; John M Kaldor
Journal:  Dev World Bioeth       Date:  2013-04-17       Impact factor: 2.294

9.  Antiretroviral therapy for prevention of HIV and tuberculosis: a promising intervention but not a panacea.

Authors:  Margaret L McNairy; Andrea A Howard; Wafaa M El-Sadr
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

10.  Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as prevention.

Authors:  Theodore C Bailey; Jeremy Sugarman
Journal:  Curr HIV Res       Date:  2013-09       Impact factor: 1.581
View more
  3 in total

1.  Early HAART Initiation May Not Reduce Actual Reproduction Number and Prevalence of MSM Infection: Perspectives from Coupled within- and between-Host Modelling Studies of Chinese MSM Populations.

Authors:  Xiaodan Sun; Yanni Xiao; Sanyi Tang; Zhihang Peng; Jianhong Wu; Ning Wang
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

2.  'Test and Treat' Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors.

Authors:  Yunia Mayanja; Onesmus Kamacooko; Daniel Bagiire; Gertrude Namale; Pontiano Kaleebu; Janet Seeley
Journal:  AIDS Behav       Date:  2018-03

3.  Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa.

Authors:  Janet Seeley; Virginia Bond; Blia Yang; Sian Floyd; David MacLeod; Lario Viljoen; Mwelwa Phiri; Melvin Simuyaba; Graeme Hoddinott; Kwame Shanaube; Chiti Bwalya; Laing de Villiers; Karen Jennings; Margaret Mwanza; Ab Schaap; Rory Dunbar; Kalpana Sabapathy; Helen Ayles; Peter Bock; Richard Hayes; Sarah Fidler
Journal:  AIDS Behav       Date:  2019-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.